2-6865636-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_207315.4(CMPK2):ā€‹c.61G>Cā€‹(p.Gly21Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,355,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000092 ( 0 hom., cov: 35)
Exomes š‘“: 0.00013 ( 0 hom. )

Consequence

CMPK2
NM_207315.4 missense

Scores

1
1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.466
Variant links:
Genes affected
CMPK2 (HGNC:27015): (cytidine/uridine monophosphate kinase 2) This gene encodes one of the enzymes in the nucleotide synthesis salvage pathway that may participate in terminal differentiation of monocytic cells. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]
RSAD2 (HGNC:30908): (radical S-adenosyl methionine domain containing 2) The protein encoded by this gene is an interferon-inducible antiviral protein that belongs to the S-adenosyl-L-methionine (SAM) superfamily of enzymes. The protein plays a role in cellular antiviral response and innate immune signaling. Antiviral effects result from inhibition of viral RNA replication, interference in the secretory pathway, binding to viral proteins and dysregulation of cellular lipid metabolism. The protein has been found to inhibit both DNA and RNA viruses, including influenza virus, human immunodeficiency virus (HIV-1) and Zika virus. [provided by RefSeq, Sep 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0055209696).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CMPK2NM_207315.4 linkc.61G>C p.Gly21Arg missense_variant 1/5 ENST00000256722.10 NP_997198.2 Q5EBM0-1
CMPK2NM_001256477.1 linkc.61G>C p.Gly21Arg missense_variant 1/4 NP_001243406.1 Q5EBM0-4
CMPK2NM_001256478.1 linkc.61G>C p.Gly21Arg missense_variant 1/4 NP_001243407.1 Q5EBM0-3
CMPK2NR_046236.2 linkn.210+790G>C intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CMPK2ENST00000256722.10 linkc.61G>C p.Gly21Arg missense_variant 1/51 NM_207315.4 ENSP00000256722.5 Q5EBM0-1

Frequencies

GnomAD3 genomes
AF:
0.0000922
AC:
14
AN:
151816
Hom.:
0
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000191
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000295
AC:
9
AN:
30554
Hom.:
0
AF XY:
0.000268
AC XY:
5
AN XY:
18634
show subpopulations
Gnomad AFR exome
AF:
0.00242
Gnomad AMR exome
AF:
0.000223
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000252
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000135
AC:
162
AN:
1203852
Hom.:
0
Cov.:
38
AF XY:
0.000127
AC XY:
75
AN XY:
588672
show subpopulations
Gnomad4 AFR exome
AF:
0.0000836
Gnomad4 AMR exome
AF:
0.0000707
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000315
Gnomad4 FIN exome
AF:
0.0000704
Gnomad4 NFE exome
AF:
0.000138
Gnomad4 OTH exome
AF:
0.0000824
GnomAD4 genome
AF:
0.0000922
AC:
14
AN:
151922
Hom.:
0
Cov.:
35
AF XY:
0.000121
AC XY:
9
AN XY:
74274
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000414
Gnomad4 FIN
AF:
0.000191
Gnomad4 NFE
AF:
0.000118
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000529
ExAC
AF:
0.000125
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 17, 2024The c.61G>C (p.G21R) alteration is located in exon 1 (coding exon 1) of the CMPK2 gene. This alteration results from a G to C substitution at nucleotide position 61, causing the glycine (G) at amino acid position 21 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
16
DANN
Benign
0.69
DEOGEN2
Benign
0.028
.;T;.
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.87
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.52
T;T;T
MetaRNN
Benign
0.0055
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.97
L;L;L
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
-0.55
N;N;N
REVEL
Benign
0.026
Sift
Uncertain
0.010
D;D;D
Sift4G
Benign
0.14
T;T;T
Polyphen
0.12
B;B;.
Vest4
0.080
MutPred
0.39
Gain of MoRF binding (P = 0.0224);Gain of MoRF binding (P = 0.0224);Gain of MoRF binding (P = 0.0224);
MVP
0.30
MPC
0.40
ClinPred
0.011
T
GERP RS
0.80
Varity_R
0.11
gMVP
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs774466405; hg19: chr2-7005767; API